Quinidine
(RONWGALEIBILOG-VCSAERELSA-N)
Structure
- SMILES
- OS(=O)(=O)O.C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O.C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O
- Molecular Formula:
- C40H50N4O8S
- Molecular Weight:
- 746.912
- Log P:
- 6.6502
- Hydrogen Bond Acceptor:
- 12
- Hydrogen Bond Donor:
- 4
- TPSA:
- 174.16
- CAS Number(s):
- 50-54-4
Synonym(s)
1.
Quinidine
2.
Adaquin
3.
Apo-Quinidine
4.
Chinidin
5.
Quincardine
6.
Quinidex
7.
Quinidine Sulfate
8.
Quinora
9.
Apo Quinidine
10.
Sulfate, Quinidine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Anti-prothrombin antibody positive | FAERS: 1 | US FAERS | |
| 2 | Antiphospholipid Antibodies | FAERS: 1 | US FAERS | |
| 3 | Asthenia | FAERS: 1 | US FAERS | |
| 4 | Dizziness | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 5 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 6 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 7 | Hypocoagulable state | FAERS: 1 | US FAERS | |
| 8 | Medication Error | FAERS: 1 | US FAERS | |
| 9 | Nausea | FAERS: 1 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 10 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 11 | Arthritis | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Cold sweat | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Disorientation | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Epistaxis | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Erythema Multiforme | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Erythema | Canada Vigilance: 2 | Canada Vigilance | |
| 18 | Fatigue | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Gastritis | Canada Vigilance: 2 | Canada Vigilance | |
| 20 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Hepatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Hypotension | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Pruritus | Canada Vigilance: 3 | Canada Vigilance | |
| 24 | Pseudolymphoma | Canada Vigilance: 1 | Canada Vigilance | |
| 25 | Purpura | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Rash erythematous | Canada Vigilance: 2 | Canada Vigilance | |
| 27 | Serum Sickness | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Somnolence | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Syncope | Canada Vigilance: 2 | Canada Vigilance | |
| 30 | Thrombocytopenia | Canada Vigilance: 5 | Canada Vigilance | |
| 31 | Thrombocytopenic purpura | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Vomiting | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.